Guillaume Onyeaghala1, Anna K Lintelmann1, Corrine E Joshu2,3, Pamela L Lutsey1, Aaron R Folsom1, Kimberly Robien4, Elizabeth A Platz2,3, Anna E Prizment1,5. 1. Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, Minnesota. 2. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. 3. Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland. 4. Department of Exercise and Nutrition Sciences, Milken Institute School of Public Health, George Washington University, Washington, DC. 5. Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.
Abstract
BACKGROUND: Adherence to the World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) cancer prevention recommendations is associated with colorectal cancer (CRC) risk in whites, but only 1 previous study has reported on this link in African Americans. This study assessed the association between the 2018 WCRF/AICR guidelines and CRC incidence in African Americans (26.5%) and whites (73.5%) in the Atherosclerosis Risk in Communities prospective cohort (n = 13,822). METHODS: A total of 368 incident CRC cases (268 among whites and 100 among African Americans) were identified between the baseline (1987) and 2012. A baseline adherence score was created for 7 WCRF/AICR guidelines (each contributing 0, 0.5, or 1 point to the score, with higher scores corresponding to greater adherence). Adherence scores were also categorized as tertiles (0.0-3.0, 3.5-4.0, and 4.5-7.0). Cox proportional hazards regression was used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) for the total cohort and with stratification by race. RESULTS: After adjustments for age, sex, race, center, smoking, education, intake of aspirin, calcium, total calories, diabetes status, and, in women, hormone replacement therapy, greater adherence was associated with decreased CRC risk. The HRs per 1-unit increment in score were 0.88 (95% CI, 0.80-0.97) for the whole cohort, 0.89 (95% CI, 0.73-1.09) for African Americans, and 0.88 (95% CI, 0.77-0.99) for whites. Similar associations between higher adherence scores and decreased cancer risk were observed for men and women and for colon cancer but not for rectal cancer. CONCLUSIONS: Greater adherence to the cancer prevention recommendations appears to be associated with decreased CRC risk for both African Americans and whites.
BACKGROUND: Adherence to the World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) cancer prevention recommendations is associated with colorectal cancer (CRC) risk in whites, but only 1 previous study has reported on this link in African Americans. This study assessed the association between the 2018 WCRF/AICR guidelines and CRC incidence in African Americans (26.5%) and whites (73.5%) in the Atherosclerosis Risk in Communities prospective cohort (n = 13,822). METHODS: A total of 368 incident CRC cases (268 among whites and 100 among African Americans) were identified between the baseline (1987) and 2012. A baseline adherence score was created for 7 WCRF/AICR guidelines (each contributing 0, 0.5, or 1 point to the score, with higher scores corresponding to greater adherence). Adherence scores were also categorized as tertiles (0.0-3.0, 3.5-4.0, and 4.5-7.0). Cox proportional hazards regression was used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) for the total cohort and with stratification by race. RESULTS: After adjustments for age, sex, race, center, smoking, education, intake of aspirin, calcium, total calories, diabetes status, and, in women, hormone replacement therapy, greater adherence was associated with decreased CRC risk. The HRs per 1-unit increment in score were 0.88 (95% CI, 0.80-0.97) for the whole cohort, 0.89 (95% CI, 0.73-1.09) for African Americans, and 0.88 (95% CI, 0.77-0.99) for whites. Similar associations between higher adherence scores and decreased cancer risk were observed for men and women and for colon cancer but not for rectal cancer. CONCLUSIONS: Greater adherence to the cancer prevention recommendations appears to be associated with decreased CRC risk for both African Americans and whites.
Authors: Dora Romaguera; Anne-Claire Vergnaud; Petra H Peeters; Carla H van Gils; Doris S M Chan; Pietro Ferrari; Isabelle Romieu; Mazda Jenab; Nadia Slimani; Françoise Clavel-Chapelon; Guy Fagherazzi; Florence Perquier; Rudolf Kaaks; Birgit Teucher; Heiner Boeing; Anne von Rüsten; Anne Tjønneland; Anja Olsen; Christina C Dahm; Kim Overvad; José Ramón Quirós; Carlos A Gonzalez; María José Sánchez; Carmen Navarro; Aurelio Barricarte; Miren Dorronsoro; Kay-Tee Khaw; Nicholas J Wareham; Francesca L Crowe; Timothy J Key; Antonia Trichopoulou; Pagona Lagiou; Christina Bamia; Giovanna Masala; Paolo Vineis; Rosario Tumino; Sabina Sieri; Salvatore Panico; Anne M May; H Bas Bueno-de-Mesquita; Frederike L Büchner; Elisabet Wirfält; Jonas Manjer; Ingegerd Johansson; Göran Hallmans; Guri Skeie; Kristin Benjaminsen Borch; Christine L Parr; Elio Riboli; Teresa Norat Journal: Am J Clin Nutr Date: 2012-05-16 Impact factor: 7.045
Authors: Nicole Jankovic; Anouk Geelen; Renate M Winkels; Blaise Mwungura; Veronika Fedirko; Mazda Jenab; Anne K Illner; Hermann Brenner; José M Ordóñez-Mena; Jessica C Kiefte de Jong; Oscar H Franco; Philippos Orfanos; Antonia Trichopoulou; Paolo Boffetta; Antonio Agudo; Petra H Peeters; Anne Tjønneland; Göran Hallmans; H Bas Bueno-de-Mesquita; Yikyung Park; Edith J Feskens; Lisette C de Groot; Ellen Kampman Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-10-28 Impact factor: 4.254
Authors: James R Cerhan; John D Potter; Julie M E Gilmore; Carol A Janney; Larry H Kushi; DeAnn Lazovich; Kristin E Anderson; Thomas A Sellers; Aaron R Folsom Journal: Cancer Epidemiol Biomarkers Prev Date: 2004-07 Impact factor: 4.254
Authors: Elizabeth A Platz; Michael F Leitzmann; Eric B Rimm; Walter C Willett; Edward Giovannucci Journal: Am J Epidemiol Date: 2004-03-01 Impact factor: 4.897
Authors: Esther K Wei; Edward Giovannucci; Kana Wu; Bernard Rosner; Charles S Fuchs; Walter C Willett; Graham A Colditz Journal: Int J Cancer Date: 2004-01-20 Impact factor: 7.396
Authors: Ariella R Korn; Jill Reedy; Nigel T Brockton; Lisa L Kahle; Panagiota Mitrou; Marissa M Shams-White Journal: Cancer Epidemiol Biomarkers Prev Date: 2022-10-04 Impact factor: 4.090
Authors: Shaneda Warren Andersen; Wei Zheng; Mark Steinwandel; Harvey J Murff; Loren Lipworth; William J Blot Journal: Cancer Prev Res (Phila) Date: 2022-09-01
Authors: Elinor Zhou; Lin Wang; Celina N Santiago; Julie Nanavati; Samara Rifkin; Emma Spence; Linda M Hylind; Joell J Gills; Louis La Luna; David R Kafonek; David M Cromwell; Julia L Drewes; Cynthia L Sears; Francis M Giardiello; Gerard E Mullin Journal: Cancer Epidemiol Biomarkers Prev Date: 2022-04-01 Impact factor: 4.090